UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination therapies in non-clear-cell renal cell carcinoma

The lancet oncology, 2023-10, Vol.24 (10), p.e401-e401

2023

Volltextzugriff (PDF)

Ribociclib-induced pulmonary infiltrates in a patient with breast cancer

Journal of oncology pharmacy practice, 2023-09, Vol.29 (6), p.1537-1540

2023

Volltextzugriff (PDF)

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Journal of clinical oncology, 2022-12, Vol.40 (34), p.4027-4027

2022

Volltextzugriff (PDF)

Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience

Journal of cancer research and therapeutics, 2020-12, Vol.16 (Supplement), p.S99-103

2020

Volltextzugriff (PDF)

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Journal of clinical oncology, 2022-07, Vol.40 (19), p.JCO2200084-2178

2022

Volltextzugriff (PDF)

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Journal of clinical oncology, 2023-01, Vol.41 (2), p.416-417

2023

Volltextzugriff (PDF)

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer

Supportive care in cancer, 2023-08, Vol.31 (8), p.500-500, Article 500

2023

Volltextzugriff (PDF)

Evaluation of scientific reliability and quality of YouTube videos on cancer and nutrition

Nutrition (Burbank, Los Angeles County, Calif.), 2023-04, Vol.108, p.111933-111933, Article 111933

2023

Volltextzugriff (PDF)

Panitumumab-induced trichomegaly

Current problems in cancer, 2021-12, Vol.45 (6), p.100748, Article 100748

2021

Volltextzugriff (PDF)

Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer

Journal of gastrointestinal cancer, 2023-12, Vol.54 (4), p.1268-1275

2023

Volltextzugriff (PDF)

Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors

Cancer chemotherapy and pharmacology, 2024-05, Vol.93 (5), p.497-507

2024

Volltextzugriff (PDF)

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

Current medical research and opinion, 2024-07, Vol.40 (7), p.1-1143

2024

Volltextzugriff (PDF)

Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Supportive care in cancer, 2023-02, Vol.31 (2), p.137, Article 137

2023

Volltextzugriff (PDF)

Niraparib-induced pure red cell aplasia

Journal of oncology pharmacy practice, 2024-01, Vol.30 (1), p.210-214

2024

Volltextzugriff (PDF)

Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study

Journal of clinical medicine, 2024-02, Vol.13 (3), p.843

2024

Volltextzugriff (PDF)

"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor"

Anti-cancer drugs, 2022-01, Vol.33 (1), p.109-111

2022

Volltextzugriff (PDF)

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

Journal of gastrointestinal cancer, 2022-09, Vol.53 (3), p.837-840

2022

Volltextzugriff (PDF)

Bone marrow involvement in breast cancer

Current problems in cancer, 2022-02, Vol.46 (1), p.100785-100785, Article 100785

2022

Volltextzugriff (PDF)

Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer

TURKISH JOURNAL OF MEDICAL SCIENCES, 2021-08, Vol.51 (4), p.1727-1732

2021

Volltextzugriff (PDF)

18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters

Nuclear medicine communications, 2020-11, Vol.41 (11), p.1199-1209

2020

Volltextzugriff (PDF)

Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy

Journal of chemotherapy (Florence), 2024-05, Vol.36 (3), p.249-257

2024

Volltextzugriff (PDF)

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

Future oncology (London, England), 2022-02, Vol.18 (5), p.533-541

2022

Volltextzugriff (PDF)

Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma

Urologic oncology, 2022-11, Vol.40 (11), p.494.e1-494.e10

2022

Volltextzugriff (PDF)

Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer

Immunotherapy, 2022-10, Vol.14 (14), p.1121-1131

2022

Volltextzugriff (PDF)

Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms

Cancer investigation, 2024-02, Vol.42 (2), p.141-154

2024

Volltextzugriff (PDF)

1 – 25 von 260

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(213)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Combination therapies in non-clear-cell renal cell carcinoma

Ribociclib-induced pulmonary infiltrates in a patient with breast cancer

Could the STELLAR Study Change the Rectal Cancer Treatment Algorithm?

Prognostic and predictive factors in cancer patients with obstructive jaundice treated by percutaneous transhepatic biliary drainage: A single-center experience

Abscobal Effect of Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer

Interpretation of the OPRA Study: Are Our Criteria Reliable Enough to Recommend Watch and Wait?

Correspondence: Significance of localized expression of full-length growth differentiation factor-15 in cachexia of advanced non-small cell lung cancer

Evaluation of scientific reliability and quality of YouTube videos on cancer and nutrition

Panitumumab-induced trichomegaly

Retrospective Analysis of Real-Life Data Evaluating the Optimal Time Between Gastrectomy and Adjuvant Chemotherapy in Resected Gastric Cancer

Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors

Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study

Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients

Niraparib-induced pure red cell aplasia

Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study

"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor"

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

Bone marrow involvement in breast cancer

Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer

18F-FDG PET/CT for primary staging of patients with testicular germ cell tumors: the predictors of 18F-FDG PET positivity and prognostic value of PET derived metabolic parameters

Oxaliplatin‑induced changes in splenic volume and liver fibrosis indices: retrospective analyses of colon cancer patients receiving adjuvant chemotherapy

Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2

Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma

Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer

Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms

Suchergebnisse filtern